Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06306768 · ClinicalTrials.gov registry record · NA

Remote Therapeutic Monitoring Exercise Tracking

A NA study of Multiple Sclerosis and Parkinson Disease, sponsored by Shirley Ryan AbilityLab.

Recruiting
Registry status
NA
Development phase
200
Enrollment target
1
Study location

NCT06306768 is a NA study of Multiple Sclerosis and Parkinson Disease that is actively recruiting participants, run by Shirley Ryan AbilityLab. The registered enrollment target is 200 participants, below the 584-participant average among 315 other Multiple Sclerosis trials with a reported enrollment target (66% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06306768, a NA study of Multiple Sclerosis and Parkinson Disease, is actively recruiting participants, sponsored by Shirley Ryan AbilityLab.

RECRUITING
Registry status
NA
Development phase
200 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to examine physical activity and exercise behaviors in people with Parkinson's Disease and Multiple Sclerosis over the course of 1-year using a cloud-based remote monitoring platform.

Interventions

  • DEVICE Activity Monitoring

Study Locations (1)

Illinois

  • Shirley Ryan AbilityLab - Chicago

Trial Details

FieldValue
Enrollment Target 200 participants
Start Date 2024-04-01
Est. Completion 2028-03
Phase NA

Sponsor

Shirley Ryan AbilityLab

138 total trials

What the Registry Record Tells You About NCT06306768

The ClinicalTrials.gov registry entry for NCT06306768 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 584-participant average among 315 other Multiple Sclerosis trials with a reported enrollment target (66% lower). The listed sponsor is Shirley Ryan AbilityLab, which has 138 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Multiple Sclerosis appearing as the primary indexed condition, and to 1 intervention - of which Activity Monitoring is the first listed.

NCT06306768 reports 1 study location spanning 1 distinct geographic area - top geographies include Illinois.

Frequently Asked Questions

What is clinical trial NCT06306768 about?

NCT06306768 is a clinical study titled "Remote Therapeutic Monitoring Exercise Tracking". The purpose of this study is to examine physical activity and exercise behaviors in people with Parkinson's Disease and Multiple Sclerosis over the course of 1-year using a cloud-based remote monitoring platform.

What is the current status of trial NCT06306768?

This trial is currently recruiting. It is a NA study. The enrollment target is 200 participants. The study started on 2024-04-01. Estimated completion is 2028-03.

What conditions does trial NCT06306768 study?

This clinical trial studies the following conditions: Multiple Sclerosis, Parkinson Disease.

What interventions are being tested in trial NCT06306768?

The interventions under investigation include: Activity Monitoring (DEVICE).

Who is sponsoring clinical trial NCT06306768?

This trial is sponsored by Shirley Ryan AbilityLab, which has 138 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06306768 being conducted?

This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Multiple Sclerosis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.